RM Drip: consolidated PAT flat YoY as margin squeeze offsets 32% revenue growth
PAT +0.08% YoY · revenue +32.51% · margins compressing
₹40.39 Cr
+32.51% YoY
₹5.31 Cr
+0.08% YoY
13.13%
-4.3pp YoY
₹0.21
R M Drip and Sprinklers Systems reported consolidated Q1 FY27 (quarter ended June 30, 2026) revenue from operations of ₹40.39 Cr, up 32.5% YoY from ₹30.48 Cr in Q1 FY26 — but consolidated PAT of ₹5.31 Cr was essentially flat YoY (+0.08%, from ₹5.31 Cr), as margin compression absorbed almost the entire revenue gain. Standalone tells the same story within 1%: PAT ₹5.35 Cr on revenue ₹40.34 Cr, so the two bases don't diverge materially this quarter — the two subsidiaries (Tuljai Agro Chemicals, Brahmanand Pipes) net to a negligible difference plus a small non-controlling interest. Both statements carry unmodified limited-review conclusions from Bilimoria Mehta & Co, though figures remain unaudited.
Q1 FY-2027 vs prior quarters
The gap between top-line and bottom-line growth sits in margins: consolidated net profit margin fell to ~13.1% from 17.4% a year ago, and operating margin (EBITDA/revenue) fell to ~22.3% from ~28.9%, a roughly 560-650bps YoY compression. That extends the trend flagged after Q4 FY26, when operating margin (ex-other income) had fallen more sharply — to 20.97% from 31.07% a year earlier, a ~1,010bps hit that had already sent the stock down over 60% YTD by June 2026. This quarter's compression is milder than Q4's but still real, with cost of materials consumed (₹23.75 Cr consolidated, up from ₹18.74 Cr YoY) rising roughly in step with revenue while other cost lines stayed comparatively controlled.
The stock went into the print at ₹17.95, down 8.7% over the past month of trading.
What the summary numbers don't show
EPS basic ₹0.21, unchanged YoY per this filing's restated comparative (our DB record showed ₹2.13 for Q1 FY26, suggesting an intervening bonus issue/split raised the share count roughly 10x).
Sequentially, consolidated revenue fell 33.9% and PAT fell 46.8% from Q4 FY26 (₹61.08 Cr revenue, ₹9.98 Cr PAT) — Q4 (Jan-Mar) is this company's seasonally heaviest quarter, so the QoQ drop by itself is not a red flag. One independent analyst review had specifically flagged Q1 FY27 as the quarter that would reveal whether the margin deterioration is temporary or structural; on that framing, margins staying compressed YoY rather than recovering leans toward the structural read. There is no formal management guidance on record and no analyst consensus estimate could be located for this quarter — coverage is thin for a stock this size — so both vsGuidance and vsStreet are marked unknown rather than assumed. No management press release or commentary is on file for this quarter to compare against the print. Separately, the Board noted the resignation of Company Secretary Gracy Vijay Kale effective August 14, 2026 (intimated August 7), and a subsidiary had earlier signed an MoU for a ₹100 Cr Maharashtra investment (announced May 6, 2026) whose capacity impact has not yet shown up in these numbers.
W1
Whether operating margin stabilizes or keeps eroding — Q1 FY27's ~22.3% is still ~560-650bps below Q1 FY26's ~28.9%, following the steeper ~1,010bps YoY hit in Q4 FY26.
W2
Progress and revenue/capacity impact of the subsidiary's ₹100 Cr Maharashtra investment MoU signed May 6, 2026.
W3
Q2 FY27 sequential trend — confirms whether the 33.9% QoQ revenue drop from Q4 FY26 is normal seasonality (Q4 is typically the strongest quarter) rather than a demand slowdown.
Unaudited, limited-review reports unmodified; source in ₹ Lakh, converted to ₹ Cr by /100. Consolidated PAT of ₹5.3126 Cr (=PBT-tax check) splits to owners ₹5.3178 Cr / NCI ₹(0.0158) Cr, which doesn't sum exactly to ₹5.3126 Cr — a ~₹1 lakh rounding quirk present in the filing's attribution table for both this quarter and the prior comparatives, not a data error on our part. DB year-ago EPS of ₹2.13 conflicts with this filing's restated comparative EPS of ₹0.21 for the same Q1 FY26 quarter, implying an intervening bonus issue/split (~10x share count) between the two records. Tuljai Agro Chemicals' consolidation status changed subsidiary→associate→subsidiary (auditor note 6); consolidated line-by-line again from Oct 13, 2025.